SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the June 2024 quarter is pegged at Rs. 118.89 millions, about 10.94% up against Rs. 107.17 millions recorded during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -0.77 millions as compared to Net Loss of Rs. -13.09 millions of corresponding quarter ended June 2023 Operating profit Margin for the quarter ended June 2024 improved to 1.51% as compared to -10.53% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 118.89 107.17 10.94 118.89 107.17 10.94 479.75 467.83 2.55
Other Income 0.73 0.76 -3.95 0.73 0.76 -3.95 3.21 3.55 -9.58
PBIDT 1.51 -10.53 -114.34 1.51 -10.53 -114.34 15.89 -18.08 -187.89
Interest 1.28 1.65 -22.42 1.28 1.65 -22.42 6.76 7.21 -6.24
PBDT 0.23 -12.18 -101.89 0.23 -12.18 -101.89 9.13 -25.29 -136.10
Depreciation 0.92 0.91 1.10 0.92 0.91 1.10 3.68 3.65 0.82
PBT -0.69 -13.09 -94.73 -0.69 -13.09 -94.73 5.45 -28.94 -118.83
TAX 0.08 0.00 0.00 0.08 0.00 0.00 3.01 -12.22 -124.63
Deferred Tax 0.08 0.00 0.00 0.08 0.00 0.00 3.01 -12.22 -124.63
PAT -0.77 -13.09 -94.12 -0.77 -13.09 -94.12 2.44 -16.72 -114.59
Equity 74.20 74.20 0.00 74.20 74.20 0.00 74.20 74.20 0.00
PBIDTM(%) 1.27 -9.83 -112.93 1.27 -9.83 -112.93 3.31 -3.86 -185.70

Guj. Terce Lab Share Price

40.05 6.15 (18.14%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×